Private company
Vincerx Pharma, Inc.
Pharmaceutical preparations company.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash | $25.0K9 | $61.8M3 | $111.5M4 | $11.7M5 | $12.8M6 | $5.0M6 | |
| Current assets | $25.0K9 | $63.1M3 | $111.8M4 | $56.0M5 | $14.7M6 | $6.4M6 | |
| Total assets | $25.0K9 | $63.2M3 | $117.7M4 | $59.3M5 | $18.2M6 | $8.0M6 | |
| Current liabilities | $44.0K10 | $37.8M3 | $13.9M4 | $9.2M5 | $5.6M6 | $5.3M6 | |
| Total liabilities | $44.0K10 | $37.8M3 | $17.4M4 | $11.6M5 | $7.0M6 | $5.3M6 | |
| Shareholders’ equity | -$44.0K3 | $25.4M4 | $100.3M5 | $47.7M6 | $11.2M6 | $2.7M6 | |
| Shares outstanding | 5.2M shares10 | 14.0M shares3 | 21.1M shares4 | 21.2M shares5 | 1.1M shares6 | 2.2M shares6 | 5.2M shares6 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Leadership
Who has led Vincerx Pharma, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
2025
- Chief executive officerAhmed Hamdy Md. Dec 28, 2020 to Aug 14, 202411
- PresidentAhmed Hamdy Md. Dec 28, 2020 to Dec 28, 202011
- Chief financial officerKevin Haas Jan 6, 2025 to Jan 6, 202512
- Chief financial officerDavid Dobkin Mar 9, 2020 to Mar 12, 202013
- Chief financial officerAlexander A. Seelenberger Dec 28, 2020 to Aug 14, 202414
- Chief operating officerMichael Yehuda Rice Mar 23, 2020 to Mar 23, 202015
Board members and other officers (21)
- OfficerAhmed Hamdy Md. Aug 10, 2023 to Aug 10, 202316
- OfficerAlexander A. Seelenberger Aug 14, 2023 to Aug 14, 202317
- Chief Medical OfficerHermes De Jesus Garban Mar 3, 2021 to Feb 16, 202218
- OfficerTom C. Thomas Mar 17, 2021 to Aug 14, 202419
- Chief Business OfficerSooin Hwang May 14, 2021 to Feb 16, 202220
- Chief Technology OfficerXiaoming Zhang Aug 16, 2021 to Feb 16, 202221
- Chief Operations OfficerRaquel E. Izumi Dec 28, 2020 to Aug 14, 202422
- Board memberRuth E. Stevens May 14, 2021 to May 28, 202423
- Board memberBarry Dennis Mar 9, 2020 to Mar 9, 202024
- Board memberBrian Schwartz Mar 9, 2020 to Mar 9, 202025
- Board memberDavid Dobkin Mar 9, 2020 to Mar 12, 202013
- Board memberKarin L. Walker Mar 9, 2020 to Mar 9, 202026
- Board memberJohn Steven Ziegler Mar 12, 2020 to Mar 12, 202027
- Board memberMichael Yehuda Rice Mar 23, 2020 to Mar 23, 202015
- Board memberAhmed Hamdy Md. Dec 28, 2020 to Aug 14, 202411
- Board memberBrian Druker Dec 28, 2020 to May 28, 202428
- Board memberChristopher P. Lowe Dec 28, 2020 to Aug 26, 202229
- Board memberFrancisco D. Salva Dec 28, 2020 to May 28, 202430
- Board memberLaura I. Bushnell Dec 28, 2020 to May 28, 202431
- Board memberMark Anthony McCamish Dec 28, 2020 to Dec 28, 202032
- Board memberRaquel E. Izumi Dec 28, 2020 to Aug 14, 202422
Former names
Timeline
- Dec 28, 2020New chief executive Ahmed Hamdy Md. becomes CEO11
Filings
219 filings to the SEC since October 2021: 4 annual reports, 11 quarterly reports, 43 major events, 66 insider forms, 22 large holders, 73 other. The latest 20:
- Jul 29, 2025SCHEDULE 13G/A EDGAR
- Jul 16, 2025DEFA14A EDGAR
- Jul 7, 2025DEFA14A EDGAR
- Jul 7, 20258-K EDGAR
- Jun 18, 2025DEFA14A EDGAR
- Jun 6, 2025DEFA14A EDGAR
- May 15, 202510-Q EDGAR
- May 15, 2025SCHEDULE 13G/A EDGAR
- May 12, 2025DEF 14A EDGAR
- May 2, 2025EFFECT EDGAR
- May 2, 2025EFFECT EDGAR
- May 2, 2025EFFECT EDGAR
- May 1, 2025S-8 POS EDGAR
- May 1, 2025S-8 POS EDGAR
- May 1, 2025S-8 POS EDGAR
- May 1, 2025S-8 POS EDGAR
- May 1, 2025S-8 POS EDGAR
- May 1, 2025POS AM EDGAR
- May 1, 2025POS AM EDGAR
- May 1, 2025POS AM EDGAR
The 219 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 22 such filings since October 2021, the latest 10:
- Jul 29, 2025SCHEDULE 13G/A
- May 15, 2025SCHEDULE 13G/A
- Feb 14, 2025SCHEDULE 13G/A
- Feb 12, 2025SCHEDULE 13G/A
- Feb 11, 2025SCHEDULE 13G/A
- Nov 14, 2024SC 13G
- Nov 14, 2024SC 13G/A
- Nov 13, 2024SC 13G/A
- May 3, 2024SC 13G
- Feb 14, 2024SC 13G/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARKevin Haas, Chief financial officer
- 13
- 14
- 15
- 16SEC EDGARAhmed Hamdy Md., Officer
- 17SEC EDGARAlexander A. Seelenberger, Officer
- 18
- 19SEC EDGARTom C. Thomas, Officer
- 20SEC EDGARSooin Hwang, Chief Business Officer
- 21
- 22
- 23SEC EDGARRuth E. Stevens, Board member
- 24SEC EDGARBarry Dennis, Board member
- 25SEC EDGARBrian Schwartz, Board member
- 26SEC EDGARKarin L. Walker, Board member
- 27SEC EDGARJohn Steven Ziegler, Board member
- 28SEC EDGARBrian Druker, Board member
- 29SEC EDGARChristopher P. Lowe, Board member
- 30SEC EDGARFrancisco D. Salva, Board member
- 31SEC EDGARLaura I. Bushnell, Board member
- 32SEC EDGARMark Anthony McCamish, Board member